ArriVent BioPharma Files For IPO
By Will Feuer ArriVent BioPharma, a clinical-stage biopharmaceutical company, filed for an initial public offering. The company plans to list its stock on...
Source: marketwatch.com
Viela Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Viela Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Viela Bio Today - Breaking & Trending Today
This Week in Chancery Court: AstraZeneca Faces Bullying Claims
The British pharmaceutical giant AstraZeneca Plc will argue before Delaware’s Court of Chancery this week that claims it pushed biotech company Viela Bio Inc. into a sale with another drug company to avoid potential antitrust concerns are “fanciful allegations.”
Source: bloomberglaw.com
Global CD19 Antibody Market and Clinical Pipeline Outlook and Competitive Landscape: Insight on 30 Key Players
/PRNewswire/ -- The "Global CD19 Antibody Market and Clinical Pipeline Outlook 2028" report has been added to ResearchAndMarkets.com's offering. CD19 targeting...
Source: prnewswire.com
Analysis Spotlights Economic Burden of Vitiligo in the US
Determining medical costs will help identify the main expenditure predictors and spending patterns, according to the authors.
Source: medscape.com
Myasthenia Gravis Treatment Market to Grow Exponentially by 2029 | Brandessence Market Research
/PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), "Myasthenia Gravis Treatment Market Size, Share Outlook...
Source: prnewswire.com